Back

Functional phenotyping combined with single-cell sequencing unmasks potential genes for hypercontractility in murine HFpEF

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Metabolic, immune, and cellular drivers of HFpEF pathogenesis and progression Signal Transduction, Mechanotransduction ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Tobias Jeising

Berlin (Germany)

7 More presentations in this session

Presentation thumbnail
Nuclear receptor co-repressor 1 promotes macrophage inflammation in heart failure with preserved ejection fraction: a translational study
Doctor E. Gorica (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Cell-type specific secretome profiling reveals targets of liver-heart interorgan crosstalk in HFpEF and semaglutide treatment
Doctor J. Schuette (Heidelberg, DE)
Abstract Slides Video
Presentation thumbnail
Disease-associated characteristics of cardiac endothelial cells and fibroblasts from a cardiomyocyte specific transgenic murine heart failure model
Mrs C. Redwanz (Greifswald, DE)
Abstract Slides Video
Presentation thumbnail
Establishment of a female HFpEF model using Dahl salt-sensitive rats and investigation of sympathetic activation-induced acute exacerbation of HFpEF
Doctor H. Nakashima (Fukuoka, JP)
Abstract Slides Video
Presentation thumbnail
Connecting cardiac energetics to transcription factor control of heart failure and regeneration
Miss C. Zhu (Frankfurt Am Main, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Metabolic, immune, and cellular drivers of HFpEF pathogenesis and progression

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Deciphering human heart failure with preserved ejection fraction (HFpEF) at single cell resolution
thumbnail
Congress Session
Basic and Translational Late-Breaking Science session
thumbnail
Congress Presentation
Multicellular trajectories leading to subclinical diastolic dysfunction and HFpEF progression in cardiometabolic comorbidities.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources